Pictet Asset Management Holding Sa Biotechnology

Pictet Asset Management Holding Sa

$93.5 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VRTX Vertex Pharmaceuticals Inc	$99.5B	$328 Million 0.35% of portfolio	735,822	Q2 2025 Added 11.29%
REGN Regeneron Pharmaceuticals, Inc.	$59.7B	$160 Million 0.17% of portfolio	304,127	Q2 2025 Added 1.05%
INSM Insmed Inc	$16.5B	$156 Million 0.17% of portfolio	1,553,628	Q2 2025 Reduced 22.83%
ALNY Alnylam Pharmaceuticals, Inc.	$52.9B	$152 Million 0.16% of portfolio	464,606	Q2 2025 Reduced 3.4%
ARGX Argenx Se	$35.3B	$109 Million 0.12% of portfolio	197,286	Q2 2025 Reduced 14.01%
BBIO Bridge Bio Pharma, Inc.	$7.28B	$78 Million 0.08% of portfolio	1,807,434	Q2 2025 Reduced 13.53%
INCY Incyte Corp	$18.2B	$74.6 Million 0.08% of portfolio	1,095,485	Q2 2025 Reduced 9.43%
TGTX Tg Therapeutics, Inc.	$3.94B	$68.7 Million 0.07% of portfolio	1,907,491	Q2 2025 Reduced 20.43%
VRNA Verona Pharma PLC	$6.41B	$63.8 Million 0.07% of portfolio	674,056	Q2 2025 Reduced 4.13%
MDGL Madrigal Pharmaceuticals, Inc.	$6.14B	$63 Million 0.07% of portfolio	208,266	Q2 2025 Added 0.59%
RARE Ultragenyx Pharmaceutical Inc.	$1.97B	$61.8 Million 0.07% of portfolio	1,699,944	Q2 2025 Added 20.63%
UTHR United Therapeutics Corp	$13.7B	$60.8 Million 0.06% of portfolio	211,417	Q2 2025 Added 5.36%
BMRN Biomarin Pharmaceutical Inc	$10.6B	$60.1 Million 0.06% of portfolio	1,093,378	Q2 2025 Added 283.24%
AKRO Akero Therapeutics, Inc.	$2.23B	$52.6 Million 0.06% of portfolio	986,633	Q2 2025 Added 213.5%
CYTK Cytokinetics Inc	$3.23B	$51.1 Million 0.05% of portfolio	1,546,391	Q2 2025 Reduced 20.95%
PTCT Ptc Therapeutics, Inc.	$3.24B	$50.9 Million 0.05% of portfolio	1,041,431	Q2 2025 Reduced 0.1%
VKTX Viking Therapeutics, Inc.	$3.06B	$50.8 Million 0.05% of portfolio	1,916,874	Q2 2025 Reduced 0.24%
MRUS Merus N.V.	$2.93B	$48.1 Million 0.05% of portfolio	915,252	Q2 2025 Reduced 11.32%
XENE Xenon Pharmaceuticals Inc.	$2.24B	$46.2 Million 0.05% of portfolio	1,474,449	Q2 2025 Reduced 0.21%
SMMT Summit Therapeutics Inc.	$5.17B	$46 Million 0.05% of portfolio	2,163,873	Q2 2025 Reduced 18.7%
NUVL Nuvalent, Inc.	$3.29B	$45 Million 0.05% of portfolio	589,832	Q2 2025 Added 6.44%
AXSM Axsome Therapeutics, Inc.	$4.51B	$43 Million 0.05% of portfolio	411,850	Q2 2025 Added 23.6%
PTGX Protagonist Therapeutics, Inc	$2.68B	$41.6 Million 0.04% of portfolio	751,977	Q2 2025 Added 154.4%
ETNB 89bio, Inc.	$420M	$39.6 Million 0.04% of portfolio	4,035,390	Q2 2025 Reduced 4.03%
PCVX Vaxcyte, Inc.	$1.78B	$38.2 Million 0.04% of portfolio	1,175,661	Q2 2025 Added 11.9%
IDYA Ideaya Biosciences, Inc.	$1.13B	$37.9 Million 0.04% of portfolio	1,805,136	Q2 2025 Reduced 1.83%
RVMD Revolution Medicines, Inc.	$3.09B	$37.2 Million 0.04% of portfolio	1,011,960	Q2 2025 Added 35.37%
MIRM Mirum Pharmaceuticals, Inc.	$2.38B	$35.7 Million 0.04% of portfolio	701,156	Q2 2025 Reduced 9.91%
SRRK Scholar Rock Holding Corp	$1.66B	$35 Million 0.04% of portfolio	987,464	Q2 2025 Added 1,009.17%
CRNX Crinetics Pharmaceuticals, Inc.	$1.53B	$34.5 Million 0.04% of portfolio	1,200,477	Q2 2025 Added 14.66%
ACAD Acadia Pharmaceuticals Inc	$4.12B	$34.2 Million 0.04% of portfolio	1,584,534	Q2 2025 Added 264.3%
IMVT Immunovant, Inc.	$3.55B	$32.7 Million 0.03% of portfolio	1,188,578	Q1 2025 Added 1.1%
RNA Avidity Biosciences, Inc.	$2.41B	$27.5 Million 0.03% of portfolio	967,602	Q2 2025 Added 10.81%
CLDX Celldex Therapeutics, Inc.	$1.11B	$26.5 Million 0.03% of portfolio	1,300,329	Q2 2025 Added 35.76%
RYTM Rhythm Pharmaceuticals, Inc.	$5.51B	$26.3 Million 0.03% of portfolio	416,115	Q2 2025 Added 60.45%
ACLX Arcellx, Inc.	$3.19B	$25.2 Million 0.03% of portfolio	383,136	Q2 2025 Added 6,882.61%
DAWN Day One Biopharmaceuticals, Inc.	$451M	$24.2 Million 0.03% of portfolio	3,722,732	Q2 2025 Added 2.4%
JAZZ Jazz Pharmaceuticals PLC	$7.1B	$24.1 Million 0.03% of portfolio	226,835	Q2 2025 Added 9.24%
IONS Ionis Pharmaceuticals Inc	$5.85B	$24 Million 0.03% of portfolio	608,640	Q2 2025 Reduced 1.6%
NRIX Nurix Therapeutics, Inc.	$472M	$22.8 Million 0.02% of portfolio	1,998,634	Q2 2025 Added 13.93%
FOLD Amicus Therapeutics, Inc.	$1.96B	$22.4 Million 0.02% of portfolio	3,907,569	Q2 2025 Added 139.99%
MRNA Moderna, Inc.	$10B	$18.8 Million 0.02% of portfolio	682,499	Q2 2025 Added 0.4%
VERA Vera Therapeutics, Inc.	$572M	$18.2 Million 0.02% of portfolio	772,814	Q2 2025 Reduced 8.03%
KRYS Krystal Biotech, Inc.	$3.69B	$17.9 Million 0.02% of portfolio	130,537	Q2 2025 Added 100.02%
VRDN Viridian Therapeutics, Inc.\De	$717M	$17.7 Million 0.02% of portfolio	1,265,754	Q2 2025 Added 1.36%
RPRX Royalty Pharma PLC	$15.7B	$17.5 Million 0.02% of portfolio	486,140	Q2 2025 Added 33.11%
EXEL Exelixis, Inc.	$12.1B	$16.8 Million 0.02% of portfolio	381,455	Q2 2025 Reduced 32.3%
JANX Janux Therapeutics, Inc.	$1.01B	$15.5 Million 0.02% of portfolio	671,485	Q2 2025 Added 2.27%
BPMC Blueprint Medicines Corp	$7.73B	$15.4 Million 0.02% of portfolio	119,817	Q2 2025 Reduced 87.45%
ASND Ascendis Pharma A/S	$10.9B	$14.8 Million 0.02% of portfolio	85,538	Q2 2025 Reduced 19.88%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Holding Sa with notifications on news.